Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
Behav Brain Res (2011) 221(2):594603
If approved, Wegovy will become the first oral GLP-1 indicated for chronic weight management
[11] [12] As with any medicine class, understanding the safety profileincluding potential long-term risks such as canceris essential for informed prescribing and patient decision-making
Remember that children should never handle fireworks, including sparklers, which can cause serious burns and eye injuries
After significant weight loss, some patients may qualify for procedures such as panniculectomy or body contouring to remove excess skin